BT474 breast cancer cells overexpress HER2, harbor PIK3CA K111N mutation [12], and respond to AKTi-1/2 in tissue culture in a fashion similar to the three PIK3CA-mutated and HER2-overexpressing breast cancer cells (Figures 1 and 3). Here, ERBB2 is linked to breast carcinoma.